R&D Pipeline -- IND-enabling activities for a PSMA-targeted ADC are on track for completion by year-end, further expanding the development portfolio.

Granted FDA Breakthrough Therapy Designation for ficerafusp alfa in combination with pembrolizumab in 1L HPV-negative R/M HNSCCData from a Phase ...

Positive Phase 1 data for CTX310® presented in a late-breaking presentation at the American Heart Association (AHA) ...

Transformational quarter puts Envoy Medical in significantly better position as it eliminated $32 million of debt, strengthened its balance sheet, and further expanded its patent ...

China has made peak carbon and carbon neutrality a national strategy, launching extensive and in-depth peak carbon ...

Gold’s (GC=F) allure has attracted retail investors in their droves and is now trading above $4,000 as the so-called “safe haven” asset has provided stability amid turmoil in the financial markets.

Hyundai Motor Group and NVIDIA will collaborate with the Korean government to develop Korea’s physical AI industry, including ...

Solstice Gold Corp. is pleased to announce that field crews have mobilized to commence a Phase II 8.9 line-km Alpha IP survey at our 100%-owned Strathy Gold Project . The Project is located in the ...

Thank you, and welcome to Pagaya Technologies Ltd.'s Third Quarter 2025 Earnings Conference Call. Joining me today to talk ...

Maplebear reported third-quarter financial results on Monday. The transcript from the company's earnings call has been ...

Circ-EGFR was identified as a novel predictive biomarker for cetuximab efficacy in KRAS wild-type metastatic colorectal ...

Continued progress across LOTIS-7 with updated data anticipated in 2025 and LOTIS-5 with topline data expected in 1H 2026 Updated data from Phase 2 IIT of ...